Urinary retention (UR) is a urological syndrome characterized by the patient’s inability to empty all the urine from the bladder. It is usually caused by obstructive diseases of the lower urinary tract (eg, benign prostatic hyperplasia [BPH] and urethral stricture), urinary tract infections and/or inflammatory diseases, and neurological disorders (eg, diabetic neuropathy, multiple sclerosis Gabapentin and Urinary Retention To determine whether there is any evidence to support an (causal) association between the administration of gabapentin and the development of urinary retention. Download PDF Studies have been carried out examining the effects of preventive measures for anaesthesia-related urinary retention, both during and after surgery, particularly into the effect of using opioids in combination with non-opioid analgesic drugs on the incidence of postoperative urinary retention. Gabapentin is a first-line agent for neuropathic pain management and has a favorable safety profile. The literature includes a few cases of gabapentin-induced incontinence, and most of them involved patients with epilepsy who were between the ages of 12 and 43 years. Herein, we present three patient Chronic urinary retention is often the result of chronic neurologic condition or benign prostatic hypertrophy. A key difference between acute and chronic urinary retention is that chronic urinary retention is often asymptomatic and rarely painful due to gradual distention of the bladder over time. I also experience urinary retention after taking gabapentin..but it’s weird because i don’t suffer from urinary retention every time i take it and i take it every night at bedtime. I not only read it online but my doctor also told me that it definitely is a side effect from gabapentin. To the best of our knowledge, the literature includes just 5 cases of gabapentin-induced incontinence, 3 of which involved both rectal and urinary incontinence and 2 involved only urinary incontinence. Spontaneous adverse drug reactions reporting databases are helpful data sources for evaluating safety profiles of and detecting potentially emerging safety signals for different pharmacological classes. Five potentially new signals of urinary retention associated with dapagliflozin, gabapentin, lithium, celecoxib, and piroxicam were found from the Italian spontaneous reporting system database Uncommon (0.1% to 1%): Hematuria, dysuria, urinary frequency, cystitis, urinary retention, vaginal hemorrhage, amenorrhea, dysmenorrhea, menorrhagia; Frequency not reported: Sexual dysfunction (including changes in libido, ejaculation disorders, and anorgasmia) Hematologic. Common (1% to 10%): Leucopenia, purpura Urinary retention (UR) is a urological syndrome characterized by the patient’s inability to empty all the urine from the bladder. It is usually caused by obstructive diseases of the lower urinary tract (eg, benign prostatic hyperplasia [BPH] and urethral stricture), urinary tract infections and/or inflammatory diseases, and neurological disorders (eg, diabetic neuropathy, multiple sclerosis In the case of urinary retention, gabapentin may help to relax the muscles in the bladder and improve the flow of urine. This can be especially helpful for people who are experiencing urinary retention due to a neurological condition, such as multiple sclerosis or spinal cord injury. Can Gabapentin Use Lead to Urinary Incontinence? - Prime MD Plus Only a few cases with GBP-associated urinary incontinence have been reported in the literature. To the authors' knowledge, these cases described individuals with only 1 attempt of the use of GBP. In this way, the present case was the first to describe a subject with the recurrence of urinary inconti The literature includes a few cases suggesting an association between gabapentin use and urinary incontinence. This case focuses on a previously unrecorded association between gabapentin and increased urinary frequency, which was dose dependent. In this analysis of the Italian spontaneous reporting system database, we found new urinary retention signals, requiring further evaluation, for dapagliflozin, gabapentin, lithium, celecoxib, and piroxicam. Urinary retention is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Multiple sclerosis. Initial management of urinary retention involves assessment of urethral patency with prompt and complete bladder decompression by catheterization. Urinary retention in Gabapentin; How the study uses the data? The study is based on gabapentin (the active ingredients of Gabapentin). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study. Acute urinary retention (AUR) is the inability to voluntarily pass urine. It is the most common urologic emergency [ 1 ]. In males, AUR is most often secondary to benign prostatic hyperplasia (BPH); AUR is rare in females [ 2,3 ]. Table 1: Drug Classes Causing Urinary Retention Drugs causing urinary retention Example medications Mechanism Anticholinergic drugs - TCAs (amitriptyline, nortryptiline) - tiotropium (Spiriva) - diphenhydramine (benadryl) - dimenhydrinate (gravol) Impaired detrusor contraction, leading to poor bladder emptying. Opioids All opioids
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |